PromoCell®, BioIVT, Cell Applications: Advanced Human Stem and Blood Cell Culture Solutions for Research, Disease Modeling, and Immunology

Reliable human stem and blood cell culture solutions are essential for breakthrough research in disease modeling and immunology. Leading brands like PromoCell®, BioIVT, and Cell Applications provide ethically-sourced cells and specialized media to ensure reproducibility and validated results. Discover how these solutions address critical industry needs for quality, documentation, and application versatility.

Why Choose Human Stem and Blood Cell Culture Solutions

• Trusted sourcing and documentation: Supports study confidence with ethically collected human primary, stem, and blood cells from approved medical centers, along with donor documentation and validated phenotypic markers.
• Stronger research relevance: Enables work with cells from multiple human tissue sources, including materials matched to disease modeling in Diabetes Type I and II and respiratory diseases such as COPD Type I to IV and asthma.
• Reproducibility support: Combines authenticated primary cells with optimized culture media to help researchers maintain expert culture conditions across demanding human cell phenotypes.
• Efficient expansion and differentiation workflows: Provides specialty media and differentiation systems that support the expansion and directed differentiation of a wide variety of blood and stem cells.
• Ready-to-use immunology resources: Gives researchers access to normal and disease state PBMCs and pre-isolated immune cell subsets with guaranteed purity, sterility, and yield.
• Reliable post-thaw performance: Supports flexible study planning with cryopreserved PBMCs and immune cell subtypes that demonstrate viability and functionality after freezing.
• Better donor matching for study design: Helps meet study-specific criteria through available donor information and HLA typing for many cell types.
• Broader workflow flexibility: Extends culture options through primary human and animal cells offered across isolation, purification, subculture, growth, and cryopreserved formats.

What’s Included in Human Stem and Blood Cell Culture Portfolios

• Cell source portfolio: Adult stem and blood cells are available from normal human bone marrow, umbilical cord tissue, placenta, adipose tissue, peripheral blood, and cord blood.
• Primary cell range: The portfolio includes validated, ethically-sourced human primary cells, human stem cells, and human blood cells.
• Tissue coverage: Authenticated primary cells are offered from dozens of human tissue sources with formulated media.
• Mesenchymal stem cell formats: Human mesenchymal stem cells are available from umbilical cord, bone marrow, and adipose tissue.
• Stem cell media formulations: Stem cell growth media are available in lowserum and defined, xeno-free formulations.
• Differentiation media systems: Differentiation reagents include media specialized for osteogenic, neurogenic, chondrogenic, and adipogenic differentiation.
• Hematopoietic progenitor cell attributes: Human blood progenitor cells are validated to be positive for CD34 and are isolated from cord blood from a single donor.
• Hematopoietic culture media: The hematopoietic progenitor media portfolio includes serum-free medium for in vitro expansion performance and traditional culture media suitable for CFU-based assays like long-term culture initiation (LTC-IC).
• Blood cell differentiation media: Differentiation media are available for M1 or M2 macrophages and for immature and fully mature myeloid dendritic cells from peripheral blood monocytes.
• Monocyte and macrophage offerings: Primary human CD14⁺ monocytes and M1 or M2 monocyte-derived macrophages are also available.
• Mononuclear cell options: Human mononuclear cells are available from cord blood and peripheral blood.
• Immune cell subset collection: Portfolio coverage for PBMCs and pre-isolated immune cell subsets, including normal and disease-state material.
• Cryopreserved formats: PBMCs, immune cell subtypes, and diverse primary cells offered in cryopreserved formats for flexible study scheduling.
• Quality attributes: Pre-isolated immune cell subsets are provided with guaranteed purity, sterility, and yield.
• Donor characterization: HLA typing is available for many cell types, and specific donor information is available to meet study-specific criteria.
• Culture media architecture: High-quality media that simulate the in vivo environment and optimized differentiation media systems are available for all cell types.
• 3D culture reagents: Media and reagents for 3D culture from patient cancers are part of the portfolio.
• Cancer culture system: Unique formulations include the Primary Cancer Culture System for selective culture of malignant cells from primary tumors or patient xenografts.
• Collection and documentation: Human primary cells are ethically collected at approved medical centers, with donor documentation and validated phenotypic markers, supporting regulatory and publication requirements.
• Primary cell processing scope: Isolation, purification, subculture, and growth of human and animal primary cells are covered within the available primary cell offerings, reducing the need to source from multiple vendors.

How These Solutions Are Used in Research

• Disease modeling: Human primary cells from relevant tissues are used for disease modeling in Diabetes Type I and II, as well as respiratory diseases including COPD Type I to IV and asthma.
• Cancer studies: Human primary and stem cell culture solutions support cancer studies, including 3D culture from patient cancers and selective culture of malignant cells from primary tumors or patient xenografts through the Primary Cancer Culture System.
• 3D and specialized culture models: Available protocols support tumor spheroid formation, culturing human cardiac myocytes, and organotypic air-liquid interface (ALI) 3D skin cultures.
• Immunology assays: PBMCs and pre-isolated immune cell subsets are used in ADCC, T cell killing assays, drug toxicity assays, and related immune cell studies.
• Blood and stem cell expansion: Specialty media are used for the expansion and differentiation of a wide variety of blood and stem cells in vitro.
• Mesenchymal stem cell differentiation: Human mesenchymal stem cells from umbilical cord, bone marrow, and adipose tissue are cultured with differentiation media for osteogenic, neurogenic, chondrogenic, and adipogenic phenotypes.
• Hematopoietic progenitor cell culture: CD34-positive human blood progenitor cells from cord blood are used with serum-free expansion media and with traditional culture media suitable for CFU-based assays such as long-term culture initiation (LTC-IC).
• Myeloid cell generation: Differentiation media support the generation of M1 or M2 macrophages, as well as immature and fully mature myeloid dendritic cells, from peripheral blood monocytes.
• Monocyte and macrophage studies: Primary human CD14⁺ monocytes and M1 or M2 monocyte-derived macrophages are available for blood cell culture and differentiation workflows.

Products Under Human Stem and Blood Cell Culture

With over 23 years of expertise, Chemical Express is the trusted official distributor of Merck in Thailand and leading brands like PromoCell®, BioIVT, and Cell Applications. Access high quality human stem and blood cell culture solutions and a comprehensive product portfolio through Chemical Express to support your research.